Teva Pharmaceuticals USA recalls Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufa
Recalled February 9, 2022 · FDA recall D-0461-2022 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient · FDA Class II
Units
6205 100-count bottles
Sold at
Nationwide in the USA
Description
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
Product
Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →